Literature DB >> 10377081

Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel.

J Wei1, D W Wang, M Alings, F Fish, M Wathen, D M Roden, A L George.   

Abstract

BACKGROUND: Congenital long-QT syndrome (LQTS) is an inherited condition of abnormal cardiac excitability characterized clinically by an increased risk of ventricular tachyarrhythmias. One form, LQT3, is caused by mutations in the cardiac voltage-dependent sodium channel gene, SCN5A. Only 5 SCN5A mutations have been associated with LQTS, and more work is needed to improve correlations between SCN5A genotypes and associated clinical syndromes. METHODS AND
RESULTS: We researched a 3-generation white family with autosomal dominant LQTS who exhibited a wide clinical spectrum from mild bradycardia to sudden death. Molecular genetic studies revealed a single nucleotide substitution in SCN5A exon 28 that caused the substitution of Glu1784 by Lys (E1784K). The mutation occurs in a highly conserved domain within the C-terminus of the cardiac sodium channel containing multiple, negatively charged amino acids. Two-electrode voltage-clamp recordings of a recombinant E1784K mutant channel expressed in Xenopus oocytes revealed a defect in fast inactivation characterized by a small, persistent current during long membrane depolarizations. Coexpression of the mutant with the human sodium channel beta1-subunit did not affect the persistent current, even though we did observe shifts in the voltage dependence of steady-state inactivation. Neutralizing multiple, negatively charged residues in the same region of the sodium channel C-terminus did not cause a more severe functional defect.
CONCLUSIONS: We characterized the genetics and molecular pathophysiology of a novel SCN5A sodium channel mutation, E1784K. The functional defect exhibited by the mutant channel causes delayed myocardial repolarization, and our data on the effects of multiple charge neutralizations in this region of the C-terminus suggest that the molecular mechanism of channel dysfunction involves an allosteric rather than a direct effect on channel gating.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377081     DOI: 10.1161/01.cir.99.24.3165

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  42 in total

1.  Channel cytoplasmic loops alter voltage-dependent sodium channel activation in an isoform-specific manner.

Authors:  E S Bennett
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

2.  Structural effects of an LQT-3 mutation on heart Na+ channel gating.

Authors:  M Tateyama; H Liu; A-S Yang; J W Cormier; R S Kass
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

3.  Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.

Authors:  Hai Huang; Silvia G Priori; Carlo Napolitano; Michael E O'Leary; Mohamed Chahine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

Review 4.  A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.

Authors:  Lars S Maier
Journal:  J Cardiovasc Pharmacol       Date:  2009-10       Impact factor: 3.105

Review 5.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

6.  Isoform-specific effects of sialic acid on voltage-dependent Na+ channel gating: functional sialic acids are localized to the S5-S6 loop of domain I.

Authors:  Eric S Bennett
Journal:  J Physiol       Date:  2002-02-01       Impact factor: 5.182

7.  Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin.

Authors:  Franck Potet; Benjamin Chagot; Mircea Anghelescu; Prakash C Viswanathan; Svetlana Z Stepanovic; Sabina Kupershmidt; Walter J Chazin; Jeffrey R Balser
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

8.  SCN5A (NaV1.5) Variant Functional Perturbation and Clinical Presentation: Variants of a Certain Significance.

Authors:  Brett M Kroncke; Andrew M Glazer; Derek K Smith; Jeffrey D Blume; Dan M Roden
Journal:  Circ Genom Precis Med       Date:  2018-05

9.  ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.

Authors:  Dan Hu; Hector Barajas-Martínez; Andre Terzic; Sungjo Park; Ryan Pfeiffer; Elena Burashnikov; Yuesheng Wu; Martin Borggrefe; Christian Veltmann; Rainer Schimpf; John J Cai; Gi-Byong Nam; Pramod Deshmukh; Melvin Scheinman; Mark Preminger; Jonathan Steinberg; Angélica López-Izquierdo; Daniela Ponce-Balbuena; Christian Wolpert; Michel Haïssaguerre; José Antonio Sánchez-Chapula; Charles Antzelevitch
Journal:  Int J Cardiol       Date:  2014-01-04       Impact factor: 4.164

10.  The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.

Authors:  Naomasa Makita; Elijah Behr; Wataru Shimizu; Minoru Horie; Akihiko Sunami; Lia Crotti; Eric Schulze-Bahr; Shigetomo Fukuhara; Naoki Mochizuki; Takeru Makiyama; Hideki Itoh; Michael Christiansen; Pascal McKeown; Koji Miyamoto; Shiro Kamakura; Hiroyuki Tsutsui; Peter J Schwartz; Alfred L George; Dan M Roden
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.